<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
14141-687-02
</NDCCode>
<PackageDescription>
1 BOTTLE in 1 BOX (14141-687-02) > 30 mL in 1 BOTTLE (14141-687-01)
</PackageDescription>
<NDC11Code>
14141-0687-02
</NDC11Code>
<ProductNDC>
14141-687
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Lbel Effet Parfait Signs Of Age Appearance Minimizer Foundation Spf 20 Fm
</ProprietaryName>
<ProprietaryNameSuffix>
Medium 7 - Beige
</ProprietaryNameSuffix>
<NonProprietaryName>
Octinoxate And Titanium Dioxide
</NonProprietaryName>
<DosageFormName>
LOTION
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20191202
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part352
</ApplicationNumber>
<LabelerName>
Bel Star S.A. (Colombia)
</LabelerName>
<SubstanceName>
OCTINOXATE; TITANIUM DIOXIDE
</SubstanceName>
<StrengthNumber>
.07; .0244
</StrengthNumber>
<StrengthUnit>
g/mL; g/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2023-12-20
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20231231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20191202
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>